Emergency situations can occur anywhere, airports and other public areas and obviously in hospitals. These places should be sufficiently equipped with emergency facilities, such as emergency stretchers.
Epidiolex, compounded from decontaminated cannabidiol, or CBD, permitted for two atypical types of epilepsy, would be the first prescription medication extracted from the marijuana plant, expected to reach pharmacies this fall.
Hypotrichosis is defined as the condition of abnormal hair patterns which leads to predominant loss or reduction. Usually, hair growth is normal after birth, but later, hair starts shedding and is replaced by abnormal hair growth patterns. The new hair will be short and brittle without pigmentation.
Axiostat, the first US Food and Drug Administration (USFDA) approved wound dressing product from India is a user-friendly, compact pack of 8X8 centimeters which ceases unrestrained bleeding from wounds. When applied on a wound, the patch acts on the blood and forms a clot in a minute and turns into a very sticky adhesive patch.
Adherium, the makers of inhaler sensors, has received 510(k) US-FDA clearance for the sales of its Hailie sensor, previously known as Smartinhaler. The individual versions of this device were previously cleared for use with the asthma inhalers like Ventolin HFA, ProAir HFA, and Flovent HFA.
Endomag received premarket approval from the FDA for Magtrace, the novel non-radioactive dual-tracer for lymphatic plotting in breast cancer patients which facilitates the implementation of magnetic detection during sentinel lymph node biopsy procedures to spot sentinel lymph nodes for surgical excision.
A new therapeutic pill named elagolix will now become available for endometriosis-related pain, after getting approved by the US Food and Drug Administration. This newly-approved drug can be taken for longer durations but also has several side-effects like headaches, hot flushes and nausea.
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.